Analysis Ascelia Pharma: Enhancing value

Ascelia  has filed a patent application for a more user friendly formulation for the contrast agent Mangoral. If approved, the patent extends to 2040. Prospects for a longer market exclusivity leads us to increase fair value.

Read the full report (Swedish) here.